Can incretin-based therapy and SGLT-2 inhibitors may be useful in the treatment of diabetes type 1?

被引：0
|
作者：
Rozanska, Paulina [1 ]
Wierusz-Wysocka, Bogna [1 ]
Zozulinska-Ziolkiewicz, Dorota [1 ]
机构：
[1] Uniwersytetu Med Karola Marcinkowskiego Poznaniu, Katedra & Klin Chorob Wewnetrznych & Diabetol, Poznan, Poland
来源：
CLINICAL DIABETOLOGY | 2015年 / 4卷 / 04期
关键词：
diabetes mellitus type 1; incretin-based therapy; SGLT-2; inhibitors;
D O I：
10.5603/DK.2015.0015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
It is known, that insulin therapy is essential in the treatment of type 1 diabetes. Insulin therapy has been related with some side effects such as hypoglycemia and weight gain, strongly connected with insulin resistance. Therefore the metformin is used sometimes as additive therapy In patients with type 1 diabetes. Recently, glukagon-like peptide 1 (GLP-1) analogs, dipeptydyl peptidase 4 (DPP-4) inhibitors and sodium glucose co-transporter 2 inhibitors (SGLT-2) has been raported to be beneficial for the glycemic control in type 1 diabetic.
引用
收藏
页码：147 / 151
页数：5
相关论文
共 50 条
  • [11] New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy
    Mitsuyoshi Namba
    Tomoyuki Katsuno
    Yoshiki Kusunoki
    Toshihiro Matsuo
    Masayuki Miuchi
    Jun-ichiro Miyagawa
    Clinical and Experimental Nephrology, 2013, 17 : 10 - 15
  • [12] New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy
    Namba, Mitsuyoshi
    Katsuno, Tomoyuki
    Kusunoki, Yoshiki
    Matsuo, Toshihiro
    Miuchi, Masayuki
    Miyagawa, Jun-ichiro
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (01) : 10 - 15
  • [13] Incretin-based Combination Therapy in Type 2 Diabetes Mellitus
    Kim, Jae Hyeon
    Lee, Myung -Shik
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2009, 52 (10): : 1030 - 1036
  • [14] Effect of the SGLT-1 and SGLT-2 Inhibitors Sotagliflozine on the Treatment of Type 1 Diabetes mellitus
    Pavlicek, Vojtech
    DIABETOLOGE, 2019, 15 (06): : 585 - 586
  • [15] Use of SGLT-2 inhibitors in the treatment of type 2 diabetes mellitus
    Santos, Leyna Leite
    Camello De Lima, Fernando Jose
    De Sousa-Rodrigues, Celio Fernando
    Barbosa, Fabiano Timbo
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (07): : 636 - 641
  • [16] The nephrological perspective on SGLT-2 inhibitors in type 1 diabetes
    Gillard, Pieter
    Schnell, Oliver
    Groop, Per-Henrik
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 170
  • [17] Incretin-based therapy: A powerful and promising weapon in the treatment of type 2 diabetes mellitus
    Koliaki C.
    Doupis J.
    Diabetes Therapy, 2011, 2 (2) : 101 - 121
  • [18] SGLT-2 INHIBITORS AS ADJUNCT THERAPY IN TYPE 1 DIABETES: REASON FOR HOPE AND CAUTION
    Lane, Wendy
    ENDOCRINE PRACTICE, 2016, 22 (03) : 371 - 373
  • [19] SGLT-2 inhibitors and their potential in the treatment of diabetes
    Rosenwasser, Rebecca F.
    Sultan, Senan
    Sutton, David
    Choksi, Rushab
    Epstein, Benjamin J.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2013, 6 : 453 - 467
  • [20] SGLT-2 inhibitors as second-line therapy in type 2 diabetes
    Tahrani, Abd A.
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (09): : 678 - 679
12345